Drug Discovery and Development Industry in the United States: Market Research Reports, Statistics and Analysis

Lorus Therapeutics Inc. - Company Report For Year 2013

... Of additional quantities of lor-253, increased clinical costs associated with the lor-253 phase i clinical trial as well as spending on our il-17e and lor-500 programs initiated and escalated in the current ...

Drug Discovery And Development Sector In The United States And S ...

... Progression modelling at gsk, uk and chdr, the netherlands danny lowe, cfo part time: previously cfo for several public companies in the drug discovery, alternative energy and mineral resources sector advisors ...

Evotec Ag - Company Report For Year 2013

... Screening, compound management, fragmentierte wirkstoffforschung, medizinalchemie und in-vivo- pharmakologie, in-vivo-admet-assays sowie eine chemische proteomik-plattform. Dazu hat das unternehmen eine ...

The United States: Brief Outlook, 2013, Focus On Drug Discovery A ...

Company Report: Drug Discovery And Development In The United Stat ...

Cowen And Company L.l.c. - Company Report For Year 2013

... The close, acelrx announced positive top-line data from the first placebo-controlled pivotal phase iii clinical trial that evaluated arx-01, the company S patient-controlled analgesia (pca) system ...

Fuso Pharmaceutical Industries Ltd. - Company Report For Year 201 ...

... Costs were to increase as multiple clinical trials are conducted simultaneously). 3Dm was planning on starting clinical trials for several pipeline applications, such as its alveolar bone reconstruction ...

Company Report: Drug Discovery And Development In The United Stat ...

... Or literature, among other things, to the fda as part of an ind. Some preclinical testing may continue even after the ind is submitted. An ind automatically becomes effective 30 days after receipt by the fda ...

Seattle Genetics Inc. - Company Report For Year 2013

... Generally, phase 3 clinical trials may take two to six years to complete. Filing of regulatory applications for marketing approval such as a biologics license application in the united states ...